GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that C. Eric Winzer, Executive Vice President and CFO, will provide an update on the Company at the 20th Annual Roth Capital Partners Growth Stock Conference.
